Inotiv
CLOSE ×
×

Study identifies novel formulation that may expand the use of ribaxamase to protect the gut microbiome from antibiotic-mediated damage

Antibiotics are well known to cause detrimental effects to the gut. However, a new formulation of ribaxamase reduced antibiotic resistance without interfering with absorption of oral amoxicillin in a recent study.

Research Models and Services Research models

Inotiv
Study identifies novel formulation that may expand the use of ribaxamase to protect the gut microbiome from antibiotic-mediated damage
Access your copy today:

Our new paper, “Study identifies novel formulation that may expand the use of ribaxamase to protect the gut microbiome from antibiotic-mediated damage” discusses a recent study utilizing canine models dosed with oral amoxicillin and formulations of ribaxamase.

One of the three formulations of ribaxamase showed great promise, since it:

  • Did not interfere with systematic absorption of the oral antibiotic
  • Reduced antibiotic resistance
  • Decreased gut microbiome alteration
Download today and learn about the potential efficacy of ribaxamase with oral antibiotics.
  • Get insights on current challenges with antibiotics
  • Understand how to defend the healthy gut microbiome
  • Read about the developing of three formulations

Download now